These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 12483964

  • 1. Elevated platelet counts and thrombocytosis in erythema nodosum leprosum.
    Rea TH.
    Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):167-73. PubMed ID: 12483964
    [Abstract] [Full Text] [Related]

  • 2. Decreases in mean hemoglobin and serum albumin values in erythema nodosum leprosum and lepromatous leprosy.
    Rea TH.
    Int J Lepr Other Mycobact Dis; 2001 Dec; 69(4):318-27. PubMed ID: 12035293
    [Abstract] [Full Text] [Related]

  • 3. Thalidomide levels in patients with erythema nodosum leprosum.
    Vieira JL, Valente Mdo S.
    Ther Drug Monit; 2009 Oct; 31(5):602-3. PubMed ID: 19704404
    [Abstract] [Full Text] [Related]

  • 4. [Thalidomide used by patients with erythema nodosum leprosum].
    Valente Mdo S, Vieira JL.
    Rev Soc Bras Med Trop; 2010 Oct; 43(2):201-4. PubMed ID: 20464154
    [Abstract] [Full Text] [Related]

  • 5. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
    de Carsalade GY, Achirafi A, Flageul B.
    Acta Leprol; 2003 Oct; 12(3):117-22. PubMed ID: 15040702
    [Abstract] [Full Text] [Related]

  • 6. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
    Feuth M, Brandsma JW, Faber WR, Bhattarai B, Feuth T, Anderson AM.
    Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of erythema nodosum leprosum using thalidomide].
    Sheskin J.
    Acta Leprol; 1983 Sep; 1(1):41-50. PubMed ID: 6401140
    [No Abstract] [Full Text] [Related]

  • 8. A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum.
    Villahermosa LG, Fajardo TT, Abalos RM, Balagon MV, Tan EV, Cellona RV, Palmer JP, Wittes J, Thomas SD, Kook KA, Walsh GP, Walsh DS.
    Am J Trop Med Hyg; 2005 May; 72(5):518-26. PubMed ID: 15891124
    [Abstract] [Full Text] [Related]

  • 9. Deep vein thrombosis: a rare complication of thalidomide therapy in recurrent erythema nodosum leprosum.
    Sharma NL, Sharma V, Shanker V, Mahajan VK, Sarin S.
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):483-5. PubMed ID: 15755204
    [Abstract] [Full Text] [Related]

  • 10. The role of thalidomide in the management of erythema nodosum leprosum.
    Walker SL, Waters MF, Lockwood DN.
    Lepr Rev; 2007 Sep; 78(3):197-215. PubMed ID: 18035771
    [Abstract] [Full Text] [Related]

  • 11. Dose-dependent thalidomide induced bradycardia in young erythema nodosum leprosum patient.
    Thangaraju P, Venkatesan S, Sivashanmugam E, Showkath Ali MK.
    Indian J Pharmacol; 2019 Sep; 51(1):72-74. PubMed ID: 31031470
    [Abstract] [Full Text] [Related]

  • 12. Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India.
    Upputuri B, Pallapati MS, Tarwater P, Srikantam A.
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008678. PubMed ID: 33035210
    [Abstract] [Full Text] [Related]

  • 13. [Bullous erythema nodosum leprosum. A case report in French Guiana].
    Couppié P, Sainte-Marie D, About V, Heid E, Pradinaud R.
    Ann Dermatol Venereol; 1998 Mar; 125(3):188-90. PubMed ID: 9747246
    [Abstract] [Full Text] [Related]

  • 14. Deep vein thrombosis in a patient with lepromatous leprosy receiving thalidomide to treat leprosy reaction.
    Hebe Petiti-Martin G, Villar-Buill M, de la Hera I, Fuertes L, Burgués-Calderón M, Rivera-Díaz R, Vanaclocha F.
    Actas Dermosifiliogr; 2013 Jan; 104(1):67-70. PubMed ID: 22705284
    [Abstract] [Full Text] [Related]

  • 15. Frequency of thromboembolic events associated with thalidomide in the non-cancer setting: a case report and review of the literature.
    Fabi SG, Hill C, Witherspoon JN, Boone SL, West DP.
    J Drugs Dermatol; 2009 Aug; 8(8):765-9. PubMed ID: 19663116
    [Abstract] [Full Text] [Related]

  • 16. IgG antibody subclasses, tumor necrosis factor and IFN-gamma levels in patients with type II lepra reaction on thalidomide treatment.
    Partida-Sanchez S, Favila-Castillo L, Pedraza-Sanchez S, Gomez-Melgar M, Saul A, Estrada-Parra S, Estrada-Garcia I.
    Int Arch Allergy Immunol; 1998 May; 116(1):60-6. PubMed ID: 9623511
    [Abstract] [Full Text] [Related]

  • 17. Recurrent erythema nodosum leprosum precipitated by antileprosy drugs.
    Bhargava P, Kuldeep CM, Mathur NK.
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):458-9. PubMed ID: 9030118
    [No Abstract] [Full Text] [Related]

  • 18. Pentoxifylline in the treatment of erythema nodosum leprosum.
    De Carsalade GY, Achirafi A, Flageul B.
    J Dermatol; 2003 Jan; 30(1):64-8. PubMed ID: 12598712
    [Abstract] [Full Text] [Related]

  • 19. Thalidomide in erythema nodosum leprosum (ENL).
    Bourdillon C.
    Lepr Rev; 1988 Jun; 59(2):184-5. PubMed ID: 3246930
    [No Abstract] [Full Text] [Related]

  • 20. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum.
    Rea TH, Sieling PA.
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):316-27. PubMed ID: 9934358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.